Get an overview of Avalyn Pharma Inc.’s MIST-PPF Clinical Trial studying inhaled pirfenidone for the treatment of progressive pulmonary fibrosis. This study aims to determine if breathing in the medicine will reach the lungs where it’s needed most, while reducing the amount that goes to other parts of the body, meaning potentially fewer side effects.
Learn about previous clinical trial results, how to participate if you have progressive pulmonary fibrosis, and what to expect.